Abstract:As life expectancy has significantly increased, age-related diseases, particularly cardiovascular diseases, have become a primary global cause of death. Aging has multiple effects on the heart and is one major risk factor for cardiovascular diseases. The microcirculation has been extensively studied in this context. However, the contribution of the lymphatic vasculature, which is responsible for draining excessive tissue fluid and immune cells, to age-related pathologies is currently unknown. To address the effect of aging on lymphatics, we examined lymphatic capillary density using LYVE1 and PDPN staining in old (>20 months) and young (3 months) mouse hearts. Aging induced a significant reduction in lymphatic vessel density in the sub-endocardial and –epicardial area of aged left ventricles, in both genders (0.28±0.08 fold and 0.68±0.03 fold; p<0.05), while the right ventricle showed no change. Notably, dilation of (pre-) collector lymphatics was observed in in old hearts, indicating, together with the lymphatic vessel reduction, a lymphatic drainage dysfunction. Indeed, cardiac aging was accompanied by increased numbers of CD68+ macrophages, accumulation of the plasma protein fibrinogen and amyloid into the interstitial space. Moreover, we observed a significant increase in tissue oedema in the aged hearts (p<0.05). The decline in lymphatic vessels was associated with a reduced expression of Vegfc (0.72±0.04 fold; p<0.005), a major lymphatic growth factor, in 20-month-old mouse hearts compared to their 3-month-old counterparts. To establish a causal link between lymphatic dysfunction and age-related cardiac changes, we examined hearts from 3-month-old Flt4;Prox1-CreERT2 mice, that have defective lymphatic vessels. Also these mice, despite their young age, displayed fibrinogen (1.32±0.08 fold; p<0.05) and CD68+ macrophage (1.58±0.08 fold; p<0.05) accumulation compared to wildtype littermates. Apart from these, other age-related changes, such as tendency to cardiac hypertrophy, were also observed; this is currently under further investigation. Likewise, blocking VEGFC signaling in young mice by overexpressing the soluble form of Flt4 impaired cardiac lymphatic capillary density (0.62±0.06 fold; p<0.01), leading to increased macrophage and fibrinogen accumulation (1.69±0.09 fold, 4.60±0.30 fold; p<0.001), suggesting that a decline of lymphatics induces some of the age-associated pathologies. Finally, we addressed whether restoring Vegfc expression in old mice can rescue age-related cardiac impairment. Overexpressing Vegfc via AAV9 in aged mice restored cardiac lymphatic density by 3-fold and reduced CD68+ macrophage density by 1.6-fold, without effect on fibrinogen accumulation. In conclusion, our study demonstrates an age-related reduction in left ventricular lymphatic density, cardiac edema and inflammation. Vegfc overexpression prevented the age-dependent decline of lymphatic vasculature and reduced cardiac inflammation.

Growth and maturation of heart valves leads to changes in endothelial cell distribution, impaired function, decreased metabolism and reduced cell proliferation

Cells and extracellular matrix interplay in cardiac valve disease: because age matters

Maturation of heart valve cell populations during postnatal remodeling

Age-Dependent Changes in Geometry, Tissue Composition and Mechanical Properties of Fetal to Adult Cryopreserved Human Heart Valves

Aging adversely impacts biological properties of human bone marrow-derived mesenchymal stem cells: implications for tissue engineering heart valve construction.

Murine aortic valve cell heterogeneity at birth

Age-Related Impairment Of Vascular Structure And Functions

Tgfβ1-Cthrc1 Signaling Plays an Important Role in the Short-Term Reparative Response to Heart Valve Endothelial Injury

Recent Progress in Vascular Aging: Mechanisms and Its Role in Age-related Diseases

Investigation of the Role of Aging on Pulmonary Microvascular Endothelial Cell Barrier Function During Mechanical Ventilation

Aging Is Associated With Organ-Specific Alterations in the Level and Expression Pattern of von Willebrand Factor

From Macro- to Micro-Vasculature and Its Implications on Cardiovascular Health

Aging impairs the neurovascular interface in the heart

Age-related decline in cardiac lymphatic vessels causes cardiac edema and macrophage accumulation

Endothelial dysfunction and angiogenesis impairment in the ageing vasculature

Cardiac changes associated with vascular aging

Vascular Stiffness in Aging and Disease

An Update on Mitral Valve Aging

Model Systems to Study the Mechanism of Vascular Aging

Mouse heart valve structure and function: echocardiographic and morphometric analyses from the fetus through the aged adult.

Cyclic nucleotide phosphodiesterase 1 and vascular aging